Intermittent Fasting Clinical Trials
2 recruiting trials for Intermittent Fasting. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Intermittent Fasting clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Zurich (1), Massachusetts General Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Modified Alternate Day Fasting (behavioral, 1 trial), followed by Time-Restricted Eating, Weight-loss counseling.
Track Intermittent Fasting trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Longitudinal Monitoring During Intermittent Fasting Protocols in Obese Adults
LIMITFOOD2 is a randomized clinical intervention study that investigates the effects of two different intermittent fasting protocols compared to a control group on the health of...
Intermittent Fasting for NAFLD in Adults
NAFLD is a growing threat to public health. Currently, there is a significant need for highly effective treatments for NAFLD. Non-obese NAFLD (BMI\<30kg/m2) is an increasingly...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Intermittent Fasting, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Intermittent Fasting, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Intermittent Fasting, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.